Previous studies suggested strokes were more common in elderly patients with severe disease, especially those with elevated levels of C-reactive protein, d-dimer, urea, and interleukin-6 (IL-6).4,5 But in the current study, the comparison with stroke in the non-COVID period showed that there was no difference in the age group of COVID-19-related stroke patients. This evidence concerns the gene IL6 and COVID-19.